[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

2 clusters · 48 sources · 8 days · First seen · Last updated

Lito Sousa medical treatment for Creutzfeldt-Jakob disease

Overview

Lito Sousa, a prominent Brazilian aviation influencer, is battling Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative condition. Despite the aggressive nature of the disease, Sousa has reportedly maintained a high level of lucidity.

To combat the disease, Sousa and his wife, Mila Seidl, sought access to experimental treatments. This effort involved coordination between the Brazilian Ministry of Health, the Ministry of Foreign Affairs, and international institutions to facilitate potential participation in clinical trials. The request was facilitated by Hospital Israelita Albert Einstein.

Following these efforts, Brazil’s National Health Surveillance Agency (Anvisa) authorized the importation and use of an experimental medication under compassionate use regulations. Mila Seidl confirmed via social media that the authorization followed established legal regulations rather than being a special exception. The process required specific documentation from pharmaceutical companies and medical examinations. The medication, which required coordination with the U.S. Food and Drug Administration (FDA), was expected to arrive in Brazil within seven to nine days from Friday, September 4, 2026.

Specifically, Anvisa authorized the import of ALN-6457, an experimental drug developed by Regeneron Pharmaceuticals. The medication is currently in a pre-clinical stage and has not yet undergone formal human studies for this specific condition. Seidl noted that the family intends to share their experience to assist other families facing rare diseases, highlighting that current procedures for accessing such treatments can be difficult to navigate due to a lack of clear information.

Entities

Ministry of Health · Lito Sousa · Hospital Israelita Albert Einstein · Mila Seidl · Itamaraty

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. 6 days ago

    [HEALTH] 30 sources
    Anvisa authorizes experimental drug import for pilot Lito Sousa

    Anvisa has authorized the compassionate use of the experimental drug ALN-6457 for pilot Lito Sousa to treat Creutzfeldt-Jakob disease, following established legal protocols.

  2. 14 days ago

    [HEALTH] 23 sources
    Lito Sousa seeks experimental treatment for rare neurodegenerative disease

    Aviation influencer Lito Sousa is seeking access to experimental drugs to combat Creutzfeldt-Jakob disease, a rare and fatal neurodegenerative condition, amid high levels of preserved cognitive function.

Sources

agorarn.com.br · alagoas24horas.com.br · areavip.com.br · bahianoticias.com.br · bemparana.com.br · blogdomarioadolfo.com.br · br.paipee.com · brasil.estadao.com.br · brasilemfolhas.com.br · bsbtimes.com.br · buxixo.com.br · dev.tnonline.com.br · diariodocentrodomundo.com.br · diarioonline.com.br · egobrazil.com.br · em.com.br · fatoamazonico.com.br · fatopaulista.com.br · freguesianews.com.br · gazetaderiopreto.com.br · gazetaweb.com · hopkinsmedicine.org · iBahia.com · inmagazine.ig.com.br · itapevinoticias.jor.br · jeremoaboagora.com.br · jovempan.uol.com.br · juruaemtempo.com.br · maisnovela.com.br · mauaagora.com.br · metro1.com.br · ndmais.com.br · nitronewsbrasil.com.br · odiariodebarretos.com.br · pnbonline.com.br · portalleodias.com · portalolm.com.br · portaltucuma.com.br · radiosampaio.com.br · rpnews.com.br · saibajanews.com.br · serious.com · siteego.com.br · tnh1.com.br · tnonline.uol.com.br · tribunadonorte.com.br · veja.abril.com.br · viagemegastronomia.com.br

This summary has been updated 3 times: see revision history